FDA Inspection 1056868 — Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd. on May 11, 2018 in Dongyang. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 11, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dongyang (China)